ISPO

molecular genetic markers

Aberrant FHIT transcripts in various leukemia

L Wang, LJ Dong, F Tian, CH Li

Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction

Y Yamada DDS PhD , N Itano PhD , H Narimatsu MD PhD , T Kudo PhD , S Hirohashi MD PhD , A Ochiai MD PhD , A Niimi DDS PhD , M Ueda DDS PhD , K Kimata PhD

Purines and pyrimidines status in different cancer cell lines and tumor tissues: A comparative study in relation to tumor suppressor protein p53

FM Al-Awadi PhD , M Alkhalaf PhD , H Al-Sayer MD

AMAS elevation precedes CAl 25 elevation in ovarian cancer and PSA elevation in prostate cancer, with both fewer false negatives and false positives

S Bogoch MD PhD, ES Bogoch MD

BRCA1 and BRCA2 variants in breast cancer patients from saudi arabia

EA El-Harith PhD , MS Abdel-Hadi FRCSI , D Steinmann MSc , T Dork PhD

Genetic alterations of chromosome 17 and p53 gene, imunoexpression of p16, pRB, p27, p53 and Ki-67 in TCCs of the bladder and their prognostic value

LL Santos MD MSc , CR Lameiras DSci , T Amaro MD , SA Pereira DSci , P Lopes DSci , MJ Bento MD , A Koch MD , CS Lopes PhD , B Criado PhD

Genome-wide search for loss of heterozygosity of breast carcinoma- an implication for mutator phenotype and breast cancer pathogenesis

CY Shen PhD, JC Yu MD, CT Yue MD PhD, YS Jou PhD, CS Huang MD PhD

Stimulation of the p53 pathway with a peptidic inhibitor of the p53-hdm2 interaction.

P Chene PhD, P Furet PhD, C Garcia-Echeverria PhD

Riboflavin carrier protein (RCP): A potential marker for primary hepatocellular carcinoma (HCC)

P Rao PhD , J Crippin MD , E Levine MD , V Prakash BS , M Myers MD , J Kopicko MSPH , P Kissinger PhD , L Myers PhD , M Raj PhD

Dysplasia as precursor of superficial bladder cancer and Carcinoma in situ (Cis) of invasive bladder tumors: molecular genetic examinations

F St Krause MD, A Zumbraegel MD, G Feil BS, T Beiter BS, K Bichler MD

PCR enrichment of chemically induced hotspot mutations in human p53 and Ki-ras sequences

L Wolz MSc, G Krause PhD, G Scherer PhD

Prediction of chemotherapy effects of gastric cancer patients treated with of CPT-11 and CDDP

N Boku MD, F Nagashima MD, A Ohtsu MD

Immunochemical isolation of antigenic lymphoma-associated proteins

K Pulford PhD, AH Banham PhD, H Roberton BSc, DY Mason MD

3q gain in solid tumours

RL Loveday PhD, JN Ashman BSc, BJ Mehigan FRCS, C Rogers FRCS, CG Grundy PhD, ND Stafford FRCS, JR Monson MD, J Greenman PhD

Cleavage of the MLL gene in acute lymphoid leukemia before treatment disappears in relapse

E Anguita MD PhD , A Villegas MD PhD , A Serra PhD , FA Gonzalez MD PhD , P Ropero PhD , T Contra MD , G Saglio MD PhD

Putative molecular markers for esophageal squamous cell carcinoma

R Mathew , S Arora , R Khanna , M Mathur , NK Shukla , R Ralhan

Analysis of genes induced by irradiation

T Imai PhD , M Sagara PhD , Y Ninomiya PhD , N Miyajima PhD , M Yamazaki PhD , H Tashiro PhD

Clonality analyses in bladder cancer by X-chromosomal inactivation, LOH and sequencing analysis following DNA preamplification using I-PEP-PCR

R Stoehr BS , R Knuechel PhD MD , F Hofstaedter PhD MD , A Hartmann MD

The role of cell cycle regulatory proteins, cyclin D1, pRb, c-myc, p16, and p27 in nasopharyngeal carcinogenesis

CL Cho PhD , EL Shih MS , JS Wang MD PhD , CF Hwang MD